Use of placebos and post-trial benefits

Abstract

Brazilian legislators have not yet enacted any laws regarding the use of placebos and the duties of assistance to research subjects. As a result of this omission, public administrative authorities have to deal with the subject on a regular basis, oriented by fundamental rights and judicial supervision. Against that backdrop, CNS (National Health Council)2, speaking through CONEP (National Research Ethics Committee)³, ANVISA (Healthcare Surveillance Agency)⁴, the CFM (Federal Medical Council)⁵, the CNJ (National Justice Council)6 and the STF (Federal Supreme Court)⁷ have expressed their opinions on the subject in a consistent manner. [...]